| For: | Luna J, Zafra J, Areses Manrique MC, Rodríguez A, Sotoca A, Fírvida JL, Chicas-Sett R, Mielgo X, Reyes JCT, Couñago F. New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer. World J Clin Oncol 2021; 12(11): 983-999 [PMID: 34909394 DOI: 10.5306/wjco.v12.i11.983] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i11/983.htm |
| Number | Citing Articles |
| 1 |
Shih-Kai Hung, Moon-Sing Lee, Wen-Yen Chiou, Dai-Wei Liu, Chih-Chia Yu, Liang-Cheng Chen, Ru-Inn Lin, Chia-Hui Chew, Feng-Chun Hsu, Hsuan-Ju Yang, Michael W. Y. Chan, Hon-Yi Lin. Epigenetic modification in radiotherapy and immunotherapy for cancers. Tzu Chi Medical Journal 2024; 36(4): 396 doi: 10.4103/tcmj.tcmj_3_24
|
| 2 |
Ping Yang, Yingnan Qiao, Mei Meng, Quansheng Zhou. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864159
|
| 3 |
Sarah Cheng, Kuan-Yi Tu, Hsin-Hua Lee. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review). Oncology Reports 2024; 52(1) doi: 10.3892/or.2024.8755
|
| 4 |
Yingchen Ruan, Minjie Ruan, Zhishen Fang, Zhihua Sun, Kuimao Zhuang, Zenan Wu, Chuanyun Yu, Zhaoguo Liu, Dehua Wu, Zhongyi Dong, Wei Wei. Assessment of pneumonitis in patients with lung cancer undergoing radioimmunotherapy and immune checkpoint inhibitor rechallenge. Communications Medicine 2026; doi: 10.1038/s43856-026-01505-w
|
| 5 |
Kim Melanie Kraus, Caroline Bauer, Benedikt Feuerecker, Julius Clemens Fischer, Kai Joachim Borm, Denise Bernhardt, Stephanie Elisabeth Combs. Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation. Cancers 2022; 14(12): 2948 doi: 10.3390/cancers14122948
|
